BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 22331471)

  • 1. Characterization of critical domains within the tumor suppressor CASZ1 required for transcriptional regulation and growth suppression.
    Virden RA; Thiele CJ; Liu Z
    Mol Cell Biol; 2012 Apr; 32(8):1518-28. PubMed ID: 22331471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CASZ1b, the short isoform of CASZ1 gene, coexpresses with CASZ1a during neurogenesis and suppresses neuroblastoma cell growth.
    Liu Z; Naranjo A; Thiele CJ
    PLoS One; 2011 Apr; 6(4):e18557. PubMed ID: 21490919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of CASZ1 NES reveals potential mechanisms for loss of CASZ1 tumor suppressor activity in neuroblastoma.
    Liu Z; Lam N; Wang E; Virden RA; Pawel B; Attiyeh EF; Maris JM; Thiele CJ
    Oncogene; 2017 Jan; 36(1):97-109. PubMed ID: 27270431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc finger transcription factor CASZ1 interacts with histones, DNA repair proteins and recruits NuRD complex to regulate gene transcription.
    Liu Z; Lam N; Thiele CJ
    Oncotarget; 2015 Sep; 6(29):27628-40. PubMed ID: 26296975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CASZ1, a candidate tumor-suppressor gene, suppresses neuroblastoma tumor growth through reprogramming gene expression.
    Liu Z; Yang X; Li Z; McMahon C; Sizer C; Barenboim-Stapleton L; Bliskovsky V; Mock B; Ried T; London WB; Maris J; Khan J; Thiele CJ
    Cell Death Differ; 2011 Jul; 18(7):1174-83. PubMed ID: 21252912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR.
    Wang C; Liu Z; Woo CW; Li Z; Wang L; Wei JS; Marquez VE; Bates SE; Jin Q; Khan J; Ge K; Thiele CJ
    Cancer Res; 2012 Jan; 72(1):315-24. PubMed ID: 22068036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution structures of the DNA-binding domains of immune-related zinc-finger protein ZFAT.
    Tochio N; Umehara T; Nakabayashi K; Yoneyama M; Tsuda K; Shirouzu M; Koshiba S; Watanabe S; Kigawa T; Sasazuki T; Shirasawa S; Yokoyama S
    J Struct Funct Genomics; 2015 Jun; 16(2):55-65. PubMed ID: 25801860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of CASZ1 tumor suppressor linked to oncogenic subversion of neuroblastoma core regulatory circuitry.
    Liu Z; Zhang X; Xu M; Lei H; Shern JF; Thiele CJ
    Cell Death Dis; 2022 Oct; 13(10):871. PubMed ID: 36243768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cloning and characterization of human Castor, a novel human gene upregulated during cell differentiation.
    Liu Z; Yang X; Tan F; Cullion K; Thiele CJ
    Biochem Biophys Res Commun; 2006 Jun; 344(3):834-44. PubMed ID: 16631614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Essential role of the zinc finger transcription factor Casz1 for mammalian cardiac morphogenesis and development.
    Liu Z; Li W; Ma X; Ding N; Spallotta F; Southon E; Tessarollo L; Gaetano C; Mukouyama YS; Thiele CJ
    J Biol Chem; 2014 Oct; 289(43):29801-16. PubMed ID: 25190801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GRHL1 acts as tumor suppressor in neuroblastoma and is negatively regulated by MYCN and HDAC3.
    Fabian J; Lodrini M; Oehme I; Schier MC; Thole TM; Hielscher T; Kopp-Schneider A; Opitz L; Capper D; von Deimling A; Wiegand I; Milde T; Mahlknecht U; Westermann F; Popanda O; Roels F; Hero B; Berthold F; Fischer M; Kulozik AE; Witt O; Deubzer HE
    Cancer Res; 2014 May; 74(9):2604-16. PubMed ID: 24419085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cells.
    Goldschneider D; Million K; Meiller A; Haddada H; Puisieux A; Bénard J; May E; Douc-Rasy S
    J Cell Sci; 2005 Mar; 118(Pt 6):1245-53. PubMed ID: 15741235
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM16 inhibits neuroblastoma cell proliferation through cell cycle regulation and dynamic nuclear localization.
    Bell JL; Malyukova A; Kavallaris M; Marshall GM; Cheung BB
    Cell Cycle; 2013 Mar; 12(6):889-98. PubMed ID: 23422002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRAB-independent suppression of neoplastic cell growth by the novel zinc finger transcription factor KS1.
    Gebelein B; Fernandez-Zapico M; Imoto M; Urrutia R
    J Clin Invest; 1998 Dec; 102(11):1911-9. PubMed ID: 9835615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.
    Wang JL; Yang MY; Xiao S; Sun B; Li YM; Yang LY
    J Exp Clin Cancer Res; 2018 Mar; 37(1):45. PubMed ID: 29506567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CASZ1b is a novel transcriptional corepressor of mineralocorticoid receptor.
    Yokota K; Shibata H; Kurihara I; Kobayashi S; Murai-Takeda A; Itoh H
    Hypertens Res; 2021 Apr; 44(4):407-416. PubMed ID: 33077905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CASZ1 promotes migration, invasion, and metastasis of lung cancer cells by controlling expression of ITGAV.
    Taheri Baghmisheh S; Wu YY; Wu JE; Hsu KF; Chen YL; Hong TM
    Am J Cancer Res; 2023; 13(1):176-189. PubMed ID: 36777515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a novel zinc finger gene, zf5-3, as a potential mediator of neuroblastoma differentiation.
    Dimitroulakos J; Pienkowska M; Sun P; Farooq S; Zielenska M; Squire JA; Yeger H
    Int J Cancer; 1999 Jun; 81(6):970-8. PubMed ID: 10362147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CASZ1 loss-of-function mutation contributes to familial dilated cardiomyopathy.
    Qiu XB; Qu XK; Li RG; Liu H; Xu YJ; Zhang M; Shi HY; Hou XM; Liu X; Yuan F; Sun YM; Wang J; Huang RT; Xue S; Yang YQ
    Clin Chem Lab Med; 2017 Aug; 55(9):1417-1425. PubMed ID: 28099117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia.
    Cardoso BA; Duque M; Gírio A; Fragoso R; Oliveira ML; Allen JR; Martins LR; Correia NC; Silveira AB; Veloso A; Kimura S; Demoen L; Matthijssens F; Jeha S; Cheng C; Pui CH; Grosso AR; Neto JL; De Almeida SF; Van Vlieberghe P; Mullighan CG; Yunes JA; Langenau DM; Pflumio F; Barata JT
    Haematologica; 2023 Dec; 109(6):1713-25. PubMed ID: 38058200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.